Centro Nacional de Investigaciones Oncológicas -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2024

  1. Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling

    Haematologica, Vol. 109, Núm. 3, pp. 877-887

2022

  1. Commentary: Genomic Analysis Reveals Heterogeneity Between Lesions in Synchronous Primary Right-Sided and Left-Sided Colon Cancer

    Frontiers in Molecular Biosciences

  2. Expression of p53 protein isoforms predicts survival in patients with multiple myeloma

    American Journal of Hematology, Vol. 97, Núm. 6, pp. 700-710

2021

  1. A clinico-pathological and molecular analysis reveals differences between solitary (early and late-onset) and synchronous rectal cancer

    Scientific Reports, Vol. 11, Núm. 1

  2. Copy neutral loss of heterozygosity (cnLOH) patterns in synchronous colorectal cancer

    European Journal of Human Genetics, Vol. 29, Núm. 4, pp. 709-713

2020

  1. Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma

    Blood Advances, Vol. 4, Núm. 23, pp. 6023-6033

2019

  1. Redefining synchronous colorectal cancers based on tumor clonality

    International Journal of Cancer, Vol. 144, Núm. 7, pp. 1596-1608